Barely Significant
← all excerpts

Distinct remission immune architectures under rituximab and azathioprine in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Front Immunol · 2026 · PMC13194602 · PMID 42183204

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The TIGIT + CD226 - fraction showed a trend toward higher values under RTX ( Figure 6C ), but this did not reach significance after multiplicity correction ( Supplementary Table 1A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.